交易 Biora Therapeutics Inc. - BIOR CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.0344 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 0.01 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Biora Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 0.5907 | -0.0505 | -7.88% | 0.6412 | 0.6612 | 0.5712 |
Apr 17, 2024 | 0.6311 | 0.0099 | 1.59% | 0.6212 | 0.6372 | 0.6112 |
Apr 16, 2024 | 0.6112 | 0.0106 | 1.76% | 0.6006 | 0.6312 | 0.5912 |
Apr 15, 2024 | 0.6012 | -0.0500 | -7.68% | 0.6512 | 0.6542 | 0.5912 |
Apr 12, 2024 | 0.6616 | -0.0200 | -2.93% | 0.6816 | 0.6816 | 0.6512 |
Apr 11, 2024 | 0.6961 | 0.0145 | 2.13% | 0.6816 | 0.6977 | 0.6713 |
Apr 10, 2024 | 0.6812 | 0.0000 | 0.00% | 0.6812 | 0.6902 | 0.6613 |
Apr 9, 2024 | 0.6912 | -0.0023 | -0.33% | 0.6935 | 0.7073 | 0.6737 |
Apr 8, 2024 | 0.7168 | 0.0056 | 0.79% | 0.7112 | 0.7187 | 0.6912 |
Apr 5, 2024 | 0.7012 | -0.0150 | -2.09% | 0.7162 | 0.7259 | 0.7011 |
Apr 4, 2024 | 0.7024 | -0.0338 | -4.59% | 0.7362 | 0.7362 | 0.6763 |
Apr 3, 2024 | 0.7362 | 0.0150 | 2.08% | 0.7212 | 0.7592 | 0.7212 |
Apr 2, 2024 | 0.7313 | 0.0001 | 0.01% | 0.7312 | 0.7362 | 0.6915 |
Apr 1, 2024 | 0.7267 | -0.0346 | -4.54% | 0.7613 | 0.8012 | 0.6612 |
Mar 28, 2024 | 1.0912 | -0.0500 | -4.38% | 1.1412 | 1.1412 | 1.0712 |
Mar 27, 2024 | 1.1612 | -0.0300 | -2.52% | 1.1912 | 1.2112 | 1.1512 |
Mar 26, 2024 | 1.2812 | 0.0400 | 3.22% | 1.2412 | 1.3112 | 1.2112 |
Mar 25, 2024 | 1.1912 | 0.0000 | 0.00% | 1.1912 | 1.2012 | 1.1412 |
Mar 22, 2024 | 1.1712 | 0.0000 | 0.00% | 1.1712 | 1.2012 | 1.1412 |
Mar 21, 2024 | 1.1812 | -0.0100 | -0.84% | 1.1912 | 1.1912 | 1.1412 |
Biora Therapeutics Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Monday, May 13, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q1 2024 Biora Therapeutics Inc Earnings Release Q1 2024 Biora Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
Thursday, June 13, 2024 | ||
时间(协调世界时) (UTC) 17:00 | 国家 US
| 事件 Biora Therapeutics Inc Annual Shareholders Meeting Biora Therapeutics Inc Annual Shareholders MeetingForecast(预报) -上一页 - |
Monday, August 12, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q2 2024 Biora Therapeutics Inc Earnings Release Q2 2024 Biora Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0.305 | 1.247 | 0.162 | 143.985 | 127.974 |
收入 | 0.305 | 1.247 | 0.162 | 143.985 | 127.974 |
收入成本,共計 | 0 | 0 | 100.492 | 92.076 | |
毛利 | 1.247 | 0.162 | 43.493 | 35.898 | |
總營業費用 | 63.686 | 119.984 | 118.981 | 284.104 | 242.213 |
銷售/一般/行政費用,總計 | 38.037 | 73.299 | 60.038 | 120.212 | 101.425 |
研究與開發 | 24.049 | 45.785 | 47.743 | 63.4 | 48.712 |
營業收入 | -63.381 | -118.737 | -118.819 | -140.119 | -114.239 |
利息收入(費用),非經營淨值 | 15.614 | -66.793 | -9.915 | -9.199 | -11.418 |
其他,淨值 | -1.483 | 6.89 | -13.884 | 0.575 | 1.801 |
稅前淨收入 | -49.25 | -178.64 | -142.618 | -148.743 | -123.856 |
稅後淨收入 | -48.83 | -178.521 | -105.086 | -148.037 | -129.106 |
未計算非常項目前的淨收益 | -48.83 | -178.521 | -105.086 | -148.037 | -129.106 |
淨收入 | -38.157 | -247.412 | -192.528 | -148.037 | -129.106 |
Total Adjustments to Net Income | 0 | -0.268 | -80.79 | 0 | |
普通股股東可獲收益 (不含非經常性項目) | -48.83 | -178.521 | -105.354 | -228.827 | -129.106 |
普通股股東可獲收益 (含非經常性項目) | -38.157 | -247.412 | -192.796 | -228.827 | -129.106 |
攤薄淨收入 | -38.157 | -247.412 | -192.796 | -228.827 | -129.106 |
攤薄後加權平均股 | 7.63511 | 3.84619 | 1.10052 | 1.80655 | 1.80655 |
扣除特別項目的每股攤薄盈利 | -6.39546 | -46.4151 | -95.7315 | -126.665 | -71.4654 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -6.21668 | -46.263 | -89.1165 | -126.665 | -71.4654 |
異常費用(收入) | 1.6 | 0.9 | 11.2 | ||
非常規項目總計 | 10.673 | -68.891 | -87.442 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.002 | 0.002 | 0.014 | 0.08 | 0.104 |
收入 | 0.002 | 0.002 | 0.014 | 0.08 | 0.104 |
收入成本,共計 | |||||
毛利 | |||||
總營業費用 | 14.936 | 15.546 | 13.79 | 13.967 | 14.314 |
銷售/一般/行政費用,總計 | 8.953 | 8.356 | 8.023 | 8.147 | 8.41 |
研究與開發 | 5.983 | 7.19 | 5.767 | 5.82 | 5.904 |
營業收入 | -14.934 | -15.544 | -13.776 | -13.887 | -14.21 |
利息收入(費用),非經營淨值 | -2.864 | -1.816 | 2.773 | -0.729 | 7.341 |
其他,淨值 | -0.005 | -0.081 | -2.207 | -0.1 | 0.035 |
稅前淨收入 | -17.803 | -17.441 | -13.21 | -14.716 | -6.834 |
稅後淨收入 | -17.807 | -17.441 | -13.469 | -14.874 | -5.997 |
未計算非常項目前的淨收益 | -17.807 | -17.441 | -13.469 | -14.874 | -5.997 |
非常規項目總計 | 0 | 0 | -0.253 | 9.76 | 0.484 |
淨收入 | -17.807 | -17.441 | -13.722 | -5.114 | -5.513 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -17.807 | -17.441 | -13.469 | -14.874 | -5.997 |
普通股股東可獲收益 (含非經常性項目) | -17.807 | -17.441 | -13.722 | -5.114 | -5.513 |
攤薄淨收入 | -17.807 | -17.441 | -13.722 | -5.114 | -5.513 |
攤薄後加權平均股 | 12.1431 | 10.9706 | 8.3577 | 7.47815 | 7.37487 |
扣除特別項目的每股攤薄盈利 | -1.46643 | -1.5898 | -1.61157 | -1.98899 | -0.81317 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.46643 | -1.5898 | -1.61157 | -1.98899 | -0.81317 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 38.116 | 98.775 | 126.338 | 74.648 | 88.946 |
現金和短期投資 | 30.486 | 88.397 | 92.076 | 33.042 | 69.205 |
現金等價物 | 30.486 | 88.397 | 92.076 | 33.042 | 49.005 |
短期投資 | 0 | 20.2 | |||
應收賬款總額,淨額 | 0.828 | 0.653 | 6.634 | 22.823 | 8.146 |
應收賬款 - 貿易,淨額 | 0 | 0.653 | 6.634 | 22.189 | 1.952 |
總庫存 | 10.937 | 7.616 | |||
預付的費用 | 3.634 | 6.123 | 8.521 | 6.476 | 3.375 |
其他流動資産,總計 | 3.168 | 3.602 | 19.107 | 1.37 | 0.604 |
總資産 | 53.525 | 108.839 | 154.44 | 101.727 | 116.397 |
物業/廠房/設備,總計 - 淨額 | 3.136 | 3.666 | 8.106 | 15.891 | 15.339 |
物業/廠房/設備,總計 - 總額 | 7.135 | 9.287 | 13.894 | 33.201 | 29.455 |
累計折舊,總計 | -3.999 | -5.621 | -5.788 | -17.31 | -14.116 |
商譽,淨額 | 6.072 | 6.072 | 6.072 | 6.219 | 6.219 |
無形資産,淨額 | 4.771 | 5.699 | |||
其他長期資産,總計 | 0.201 | 0.326 | 13.924 | 0.198 | 0.194 |
流動負債總額 | 23.305 | 61.609 | 72.67 | 100.337 | 78.057 |
應付賬款 | 3.606 | 8.709 | 17.379 | 15.754 | 11.035 |
預提費用 | 14.064 | 30.847 | 50.312 | 77.571 | 61.019 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0 | 0.012 | 0.338 | 0.968 | 1.229 |
其他流動負債,總計 | 5.635 | 22.041 | 4.641 | 6.044 | 4.774 |
負債總額 | 155.812 | 193.815 | 261.434 | 185.601 | 153.365 |
長期債務總額 | 127.811 | 126.392 | 160.203 | 72.405 | 71.508 |
長期債務 | 127.811 | 126.392 | 160.161 | 72.047 | 70.615 |
資本租賃義務 | 0.042 | 0.358 | 0.893 | ||
其他負債,總計 | 4.696 | 5.814 | 28.561 | 12.859 | 3.8 |
總權益 | -102.287 | -84.976 | -106.994 | -83.874 | -36.968 |
Preferred Stock - Non Redeemable, Net | 0.106 | 0.02 | |||
普通股 | 0.008 | 0.006 | 0.059 | 0.052 | 0.05 |
額外實收資本 | 743.626 | 722.782 | 452.992 | 283.217 | 124.202 |
留存收益(累計赤字) | -826.843 | -788.686 | -541.274 | -348.478 | -142.469 |
Treasury Stock - Common | -19.078 | -19.078 | -18.771 | -18.771 | -18.771 |
總負債和股東權益 | 53.525 | 108.839 | 154.44 | 101.727 | 116.397 |
已發行普通股總數 | 8.9285 | 7.27489 | 2.23089 | 1.80655 | 1.80655 |
長期投資 | 6 | 0 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 19.247 | 33.885 | 37.168 | 38.116 | 46.36 |
現金和短期投資 | 12.569 | 26.452 | 30.463 | 30.486 | 37.06 |
現金等價物 | 12.569 | 26.452 | 30.463 | 30.486 | 37.06 |
應收賬款總額,淨額 | 0.818 | 0.819 | 0.828 | 0.828 | 0.828 |
應收賬款 - 貿易,淨額 | 0 | 0 | |||
總庫存 | |||||
預付的費用 | 3.179 | 3.912 | 3.059 | 3.634 | 5.461 |
其他流動資産,總計 | 2.681 | 2.702 | 2.818 | 3.168 | 3.011 |
總資産 | 34.703 | 49.673 | 53.243 | 53.525 | 62.614 |
物業/廠房/設備,總計 - 淨額 | 3.07 | 3.238 | 3.744 | 3.136 | 3.955 |
物業/廠房/設備,總計 - 總額 | 5.474 | 5.637 | 6.036 | 7.135 | 7.944 |
累計折舊,總計 | -2.404 | -2.399 | -2.292 | -3.999 | -3.989 |
商譽,淨額 | 6.072 | 6.072 | 6.072 | 6.072 | 6.072 |
無形資産,淨額 | |||||
其他長期資産,總計 | 0.314 | 0.478 | 0.259 | 0.201 | 0.227 |
流動負債總額 | 69.544 | 37.668 | 25.083 | 23.305 | 27.391 |
應付賬款 | 3.905 | 5.042 | 3.422 | 3.606 | 2.356 |
預提費用 | 21.124 | 21.271 | 16.333 | 14.064 | 19.543 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0 | 0 | |||
其他流動負債,總計 | 44.515 | 11.355 | 5.328 | 5.635 | 5.492 |
負債總額 | 153.489 | 170.554 | 158.241 | 155.812 | 160.057 |
長期債務總額 | 80.378 | 128.568 | 128.185 | 127.811 | 127.445 |
長期債務 | 80.378 | 128.568 | 128.185 | 127.811 | 127.445 |
資本租賃義務 | |||||
其他負債,總計 | 3.567 | 4.318 | 4.973 | 4.696 | 5.221 |
總權益 | -118.786 | -120.881 | -104.998 | -102.287 | -97.443 |
普通股 | 0.021 | 0.011 | 0.011 | 0.008 | 0.153 |
額外實收資本 | 835.817 | 760.277 | 758.353 | 743.626 | 734.607 |
留存收益(累計赤字) | -935.545 | -862.091 | -844.284 | -826.843 | -813.121 |
Treasury Stock - Common | -19.079 | -19.078 | -19.078 | -19.078 | -19.082 |
總負債和股東權益 | 34.703 | 49.673 | 53.243 | 53.525 | 62.614 |
已發行普通股總數 | 23.411 | 13.4209 | 11.859 | 8.9285 | 7.56389 |
長期投資 | 6 | 6 | 6 | 6 | 6 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -38.157 | -247.412 | -192.528 | -148.037 | -129.106 |
经营活动产生的现金 | -64.417 | -167.486 | -165.744 | -106.124 | -65.126 |
经营活动产生的现金 | 0.907 | 1.437 | 5.059 | 6.349 | 6.073 |
Deferred Taxes | 0 | 6.245 | |||
非现金物品 | -22.517 | 104.353 | 72.895 | 2.91 | 5.501 |
Cash Taxes Paid | 0.031 | 0.367 | 0.062 | 0.006 | 0.211 |
已付现金利息 | 5.871 | 7.536 | 3.927 | 7.529 | 7.618 |
营运资金的变化 | -4.65 | -25.864 | -51.17 | 32.654 | 46.161 |
投资活动产生的现金 | -0.792 | -1.242 | -4.944 | 16.525 | 55.831 |
资本支出 | -0.792 | -0.855 | -4.944 | -3.725 | -4.832 |
其他投资现金流量项目,总计 | 0 | -0.387 | 0 | 20.25 | 60.663 |
融资活动产生的现金 | 7.298 | 165.049 | 229.722 | 73.636 | -12.807 |
融资现金流项目 | -5.12 | -5.532 | -6.745 | -4.679 | -0.25 |
股票的发行(报废),净额 | 12.43 | 172.224 | 137.742 | 79.59 | -10.807 |
债务的发行(退还),净额 | -0.012 | -1.643 | 98.725 | -1.275 | -1.75 |
现金净变化 | -57.911 | -3.679 | 59.034 | -15.963 | -22.102 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.441 | -38.157 | -24.435 | -19.321 | -13.808 |
Cash From Operating Activities | -12.098 | -64.417 | -53.399 | -43.594 | -23.955 |
Cash From Operating Activities | 0.147 | 0.907 | 0.749 | 0.547 | 0.322 |
Non-Cash Items | 2.003 | -22.517 | -22.436 | -13.221 | -5.045 |
Cash Taxes Paid | 0 | 0.031 | 0.018 | 0.017 | 0.001 |
Cash Interest Paid | 5.871 | 4.811 | 4.811 | 0 | |
Changes in Working Capital | 3.193 | -4.65 | -7.277 | -11.599 | -5.424 |
Cash From Investing Activities | -0.006 | -0.792 | -0.72 | -0.556 | -0.342 |
Capital Expenditures | -0.016 | -0.792 | -0.72 | -0.556 | -0.342 |
Cash From Financing Activities | 12.081 | 7.298 | 2.782 | 4.259 | 3.134 |
Financing Cash Flow Items | -0.802 | -5.12 | -3.748 | -0.612 | -0.48 |
Issuance (Retirement) of Stock, Net | 12.883 | 12.43 | 6.542 | 4.883 | 3.626 |
Issuance (Retirement) of Debt, Net | 0 | -0.012 | -0.012 | -0.012 | -0.012 |
Net Change in Cash | -0.023 | -57.911 | -51.337 | -39.891 | -21.163 |
Other Investing Cash Flow Items, Total | 0.01 | 0 | 0 | 0 | 0 |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
4330 La Jolla Village Drive
Suite 200
SAN DIEGO
CALIFORNIA 92122
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球610,000万多名交易者的一份子,选择利用Capital.com进行交易吧。